These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25516122)

  • 21. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.
    Canal CE; Morgan D
    Drug Test Anal; 2012; 4(7-8):556-76. PubMed ID: 22517680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinolinic acid inhibits DOI-induced head shakes in mice.
    Kariyawasam SH; Handley SL
    J Psychopharmacol; 1999; 13(3):284-6. PubMed ID: 10512085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice.
    Suemaru K; Yasuda K; Cui R; Li B; Umeda K; Amano M; Mitsuhashi H; Takeuchi N; Inoue T; Gomita Y; Araki H
    Physiol Behav; 2006 Jul; 88(4-5):545-9. PubMed ID: 16766001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL; Meltzer HY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM; Vann RE; Wiley JL
    Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
    Patel S; Hillard CJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):304-11. PubMed ID: 16569753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice.
    Ueki T; Mizoguchi K; Yamaguchi T; Nishi A; Sekiguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2015 May; 166():23-30. PubMed ID: 25732836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
    Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Directly Observable Behavioral Effects of Lorcaserin in Rats.
    Serafine KM; Rice KC; France CP
    J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis.
    Murillo-Rodríguez E; Machado S; Rocha NB; Budde H; Yuan TF; Arias-Carrión O
    Neuroscience; 2016 Dec; 339():433-449. PubMed ID: 27746343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
    Hasanein P; Shahidi S; Komaki A; Mirazi N
    Eur J Pharmacol; 2008 Sep; 591(1-3):132-5. PubMed ID: 18593578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of endocannabinoid signaling protects against cocaine-induced neurotoxicity.
    Vilela LR; Gobira PH; Viana TG; Medeiros DC; Ferreira-Vieira TH; Doria JG; Rodrigues F; Aguiar DC; Pereira GS; Massessini AR; Ribeiro FM; de Oliveira AC; Moraes MF; Moreira FA
    Toxicol Appl Pharmacol; 2015 Aug; 286(3):178-87. PubMed ID: 25933444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats.
    Toczek M; Schlicker E; Grzęda E; Malinowska B
    Life Sci; 2015 Oct; 138():78-85. PubMed ID: 25921770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test.
    Massé F; Hascoët M; Dailly E; Bourin M
    Psychopharmacology (Berl); 2006 Jan; 183(4):471-81. PubMed ID: 16307296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
    Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion: Comparison with 5-HT2A Receptor Functional Activity.
    Bazovkina DV; Kondaurova EM; Naumenko VS; Ponimaskin E
    Neural Plast; 2015; 2015():846589. PubMed ID: 26380122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors.
    Mato S; Aso E; Castro E; Martín M; Valverde O; Maldonado R; Pazos A
    J Neurochem; 2007 Dec; 103(5):2111-20. PubMed ID: 17944876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.